Sarcomatoid Dedifferentiation in Metastatic Clear Cell Renal Cell Carcinoma and Outcome on Treatment With Anti–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Retrospective Analysis

Kinase Inhibitors ◽

Clear Cell ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

MP72-06 CORRELATION OF THE INSULIN RECEPTOR EXPRESSION AND THE RESISTANCE TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

The Journal of Urology ◽

10.1016/j.juro.2018.02.2290 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Masayuki Takahashi ◽

Kei Daizumoto ◽

Yayoi Fukuhara ◽

Keisuke Ozaki ◽

Megumi Tsuda ◽

...

Keyword(s):

Kinase Inhibitors ◽

Clear Cell ◽

Growth Factor Receptor ◽

Receptor Expression ◽

Vascular Endothelial ◽

Insulin Receptor Expression ◽

Prognostic tissue biomarker exploration for patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors

Tumor Biology ◽

10.1007/s13277-015-4339-5 ◽

2015 ◽

Vol 37 (4) ◽

pp. 4919-4927 ◽

Cited By ~ 4

Author(s):

Inkeun Park ◽

Yong Mee Cho ◽

Jae-Lyun Lee ◽

Jin-Hee Ahn ◽

Dae-Ho Lee

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Tissue Biomarker ◽

Correlation of Degree of Hypothyroidism With Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.11.002 ◽

2015 ◽

Vol 13 (3) ◽

pp. e131-e137 ◽

Cited By ~ 13

Author(s):

Erin B. Bailey ◽

Srinivas K. Tantravahi ◽

Austin Poole ◽

Archana M. Agarwal ◽

Alli M. Straubhar ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Survival Outcomes ◽

Vascular Endothelial ◽

Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-012-1148-8 ◽

2012 ◽

Vol 138 (4) ◽

pp. 687-693 ◽

Cited By ~ 15

Author(s):

Jae-Lyun Lee ◽

Inkeun Park ◽

Kwonoh Park ◽

Seongjoon Park ◽

Yongcheol Ahn ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Efficacy And Safety ◽

Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a sin

BJU International ◽

10.1111/bju.13374 ◽

2015 ◽

Vol 118 (2) ◽

pp. 264-271 ◽

Cited By ~ 10

Author(s):

Marc R. Matrana ◽

Tharakeswara Bathala ◽

Matthew T. Campbell ◽

Cihan Duran ◽

Aditya Shetty ◽

...

Keyword(s):

Kinase Inhibitors ◽

Clear Cell ◽

Mammalian Target Of Rapamycin ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

First Line ◽

Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor

Acta Oncologica ◽

10.3109/0284186x.2015.1099731 ◽

2015 ◽

Vol 55 (3) ◽

pp. 329-340 ◽

Cited By ~ 6

Author(s):

Anne Sacré ◽

Philippe Barthélémy ◽

Clement Korenbaum ◽

Mickael Burgy ◽

Pascal Wolter ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Clear Cell ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Second Line ◽

Endothelial Growth Factor

Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

PLoS ONE ◽

10.1371/journal.pone.0090135 ◽

2014 ◽

Vol 9 (3) ◽

pp. e90135 ◽

Cited By ~ 31

Author(s):

Ze-Feng Zhang ◽

Tao Wang ◽

Li-Hua Liu ◽

Hui-Qin Guo

Keyword(s):

Systematic Review ◽

Growth Factor ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Medication-related osteonecrosis of the jaw incidence in patients exposed concomitantly to bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors: is it generalizable to all solid tumors?

Supportive Care in Cancer ◽

10.1007/s00520-018-4301-3 ◽

2018 ◽

Vol 27 (6) ◽

pp. 1961-1961

Author(s):

Kadri Altundag

Keyword(s):

Growth Factor ◽

Bone Resorption ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Osteonecrosis Of The Jaw ◽

Vascular Endothelial ◽

Hepatotoxicity of vascular endothelial growth factor receptor tyrosine kinase inhibitors: clinical practice and evidence

Drugs & Therapy Perspectives ◽

10.1007/s40267-017-0416-8 ◽

2017 ◽

Vol 33 (8) ◽

pp. 395-402

Author(s):

Bulent Cetin ◽

Irem Bilgetekin ◽

Mustafa Cengiz ◽

Ahmet Ozet

Keyword(s):

Clinical Practice ◽

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2014.12.008 ◽

2015 ◽

Vol 94 (2) ◽

pp. 228-237 ◽

Cited By ~ 55

Author(s):

Pooja Ghatalia ◽

Charity J. Morgan ◽

Youjin Je ◽

Paul L. Nguyen ◽

Quoc-Dien Trinh ◽

...

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽